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Granulocytes  and  monocytes  derived  from  inflammatory  exudates  or  the 
peripheral  circulation  of several mammalian species  (1-5)  can  be stimulated 
to release a pyrogen, leukocytic pyrogen (LP) 1, which induces a  characteristic 
febrile response in rabbits. Chemical characterization of LP has shown it to be 
a  protein molecule (6-8)  and since the  original discovery of its production by 
rabbit peritoneal exudate cells (9), many attempts have been made to deter- 
mine the mechanism of its synthesis by leukocytes. With  one exception  (10), 
preformed pyrogen has not been obtained from disrupted rabbit cells (11,  12). 
Its release in  vitro has  been shown  to  take place over a  several hour  period 
(4,  11,  12),  to be dependent upon the temperature of incubation  (11),  and in- 
hibited by agents which bind sulfhydryl groups in  enzymes  (13). These  find- 
ings suggest that LP is either synthesized de novo or activated from a precursor 
substance after contact with an appropriate stimulating agent. 
In the present studies, the role of RNA and protein synthesis and the energy 
requirements for pyrogen release by human peripheral leukocytes activated by 
the  ingestion  of  heat-killed  bacteria have  been  investigated.  The  results  re- 
ported here indicate that both transcription of messenger RNA and its transla- 
tion by ribosomes into new protein synthesis are essential for pyrogen produc- 
tion  by these  cells  in  vitro.  In  addition,  the  energy derived  from glycolysis 
appears to be important for the activation process. 
* The paper was presented in part at the annual meeting of the American Federation for 
Clinical Research, May 2, 1969, Atlantic City, New Jersey (1969. Clin Res. 17: 373). 
:~ Present address: National Cancer Institute, Medicine Branch, Bethesda, Maryland 20014. 
§ Present address: National Institute  of Allergy and Infectious Diseases, Laboratory  of 
Clinical Investigation, Bethesda, Maryland 20014. 
I Abbreviations used in  this  paper: HBSS, Hanks' balanced salt  solution; HMS, hexose 
monophosphate shunt;  LP, leukocytic pyrogen; MHS, modified Hanks' solution; NaF,  so- 
dium fluoride; PSB, polystyrene balls; PWBC, phagocytes (monocytes and granulocytes); 
m-RNA, messenger RNA; s-RNA, soluble RNA. 
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Materials and Methods 
Materlals.--Alt needles, syringes, media and solutions were sterile and pyrogen-free. 
Leukocytes.--Whole, anticoagulated  (ACD)  human blood was obtained daily and centri- 
fuged at 1500 g for 3 rain. The buffy coat (approximately 75 ml per unit of whole blood) was 
aspirated with sterile precautions. Further separation of white and red blood cells was achieved 
by the addition of homologous plasma in a  2:1  ratio  (by volume) to the buffy coat, and the 
cells were allowed to sediment for 11/4 hr at 37°C. The supernatant, containing mostly white 
and a few red blood cells, was aspirated and the white blood cells counted in an electronic par- 
ticle counter.  2 200 cell differential counts were made on smears prepared with Wright's stain 
to determine the number of phagocytes (monocytes and granulocytes, PWBC) in the prepara- 
tion, since these have been shown to be the only cells capable of LP release (3, 4, 14). 
Reagents.--Escherlchia coli endotoxin  3 was diluted in modified Hanks' solution  4 (MHS) to a 
concentration of 0.3 #g/mt. To produce leukocytic pyrogen, 1 ml of endotoxin was added to 
100 X  106 PWBC to give a final concentrationof 0.03 #gendotoxinper ml of solution. Staphylo- 
coccus albus isolated from a patient was grown in a semisolid media and kept at room tempera- 
ture as a stock supply. When needed, a loopful was incubated overnight at 37°C in trypticase 
soy broth. The culture was centrifuged at 1500 rpm for 20 min and washed once in MHS. The 
bacteria were boiled for 30 min in a water bath and cultured to insure sterility. The final con- 
centration was determined by densitometry at 650 m#. 5 To stimulate the release of LP, a bac- 
teria to PWBC ratio of 40:1 was used. 
Drugs employed were of analytic grade and obtained from commercial sources, except cyclo- 
heximideP Solutions of acfinomycin D  (50 #g/ml), vincristine (2  X  10 -4 M), and cyclohexi- 
mide  (25  #g/ml)  were prepared daily.  Puromycin  (4  X  10-5 •)  was prepared weekly, and 
sodium fluoride (NaF)  (2  X  10  -1 M) and potassium cyanide (KCN)  (1  X  10  -2 ~) every 2-3 
wk. All drugs were diluted in MHS and stored at 4°C. Drugs were added to the final cell sus- 
pensions to give a  10-fold dilution from the above concentrations. 
Preparation of Leukocyti6 Pyrogen.--Volumes  of white  blood cell-rich plasma containing 
100 X  106 phagocytic cells (granulocytes and monocytes) were pipetted into 40 ml test tubes. 
These were centrifuged at 800 rpm (150 g) for 8-10 rain at 4°C and the plasma decanted. To 
each portion of 100  X  l0  s phagocytic cells was added 1.5 ml of plasma (15% of final volume) 
and various drugs, killed S. albus, or endotoxin as required by the experiment. The volume of 
each sample was then made up to 10 ml by the addition of MHS containing 10 units of heparin 
per ml. The test tubes were placed in a shaking incubator  7 at 37°C for an appropriate period 
of time. At the termination of the experiment, all solutions were centrifuged at 3000 rpm for 1 
hr at 4°C to remove S. albus, and portions were cultured in thioglycollate broth for 72 hr before 
injection into rabbits. Contaminated material was discarded and sterile solutions were stored 
at 4°C until used. 
Fever Measurement.--New Zealand white rabbits of either sex weighing 1.5  to 2.5 kg from 
the same colony (National Institutes of Health, Bethesda, Md.) were used. Details of housing, 
feeding,  training,  and  temperature recording were as previously reported  (15).  Only  those 
rabbits with stable baseline temperatures for at least the preceding 30 rain were injected. A 
rise in  temperature of less than 0.3°C was not considered meaningful.  Each solution to be 
tested was injected into at least three rabbits. No rabbit was used more than once each day, 
2 Coulter Electronics, Hialeah, Fla. 
3 Difco Laboratories, Inc., Detroit, Mich. 
4 K2H2PO4,  1.568 g/liter; NaC1, 8.124 g/liter; dextrose, 2 g/liter; distilled H20 to 1000 ml. 
5 Coleman junior speetrophotometer. 
6 Cancer Chemotherapy National Service Center, Bethesda, Md. 
7 Model 5970, New Brunswick Scientific Co., New Brunswick, N. J. NORDLUND,  ROOT~ AND  WOLFF  729 
and all were discarded after three injections or 3 days after their first injection to prevent the 
development of fevers due to hypersensitivity to human proteins. Those animals receiving 
leukocytic pyrogen obtained from endotoxin activated cells were given 1.5 #g endotoxin intra- 
venously on the preceding day to induce febrile tolerance (16). 
Phagocytosis.--To quantitate phagocytosis, cell suspensions were prepared in an identical 
manner to those used for pyrogen assays. Drugs were added as described, and S. albus was 
added in a 40:1 ratio to PWBC. The suspension was then placed in an agitator at 37°C  and 
allowed to incubate for 1 hr. To concentrate the PWBC, the suspensions were centrifuged at 
1500  rpm for 20 min, the supernatants discarded,  and  1 ml of plasma added.  Smears were 
stained with Wright's stain, and the per cent of 100-200 PWBC's contMning intracellular S. 
a/bus were enumerated. 
Hexose Monophosphate Shunt A ctivity.--To assay metabolic responsiveness of cells and their 
phagocytic capacity, the release of labeled CO2 from the hexose monophosphate shunt (I-IMS) 
was measured (17).  The method of Skeel (18) was duplicated with  minor exceptions. 14C-I- 
glucose  s was diluted to 1.0/zCi per ml in Hanks' balanced salt solution (HBSS).  9 Polystyrene 
balls (PSB) 1° with a diameter of 1.099/z =~ 0.0059 were diluted 1:5 in I-IBSS. 1/~ ml of lac-1- 
glucose was added to each reaction mixture and 0.5 ml of drug when required by the experi- 
ment. HBSS was added to bring the volume to 3 ml. 1 ml of plasma prepared to contain 10 X 
106 PWBC was then added and the flasks immediately capped with rubber stoppers  n  to which 
a polyethylene cup  n  was attached. Into each cup, 0.2 ml of 10% potassium hydroxide, made 
fresh weekly, was injected with a  tuberculin syringe. The mixtures were placed in a Dubnoff 
shaker-incubator at 37~C for 1 hr and the reaction terminated by the addition of 1 ml of 1 N 
hydrochloric acid to the cell suspension. The polyethylene cups were then gently removed and 
placed into counting vials which contained 20 ml of a scintillation solution. This latter mixture 
was prepared with 40 ml of Liquifluor  1~, 660 ml of toluene, and 300 ml of absolute methanol. 
The vials were then counted in a liquid scintillation counter  la to insure an error of less than 
15% 
RESULTS 
Production  Rate of LP.--Prior  to examining whether the agents employed affected 
the activation or release phases of pyrogen production, it was necessary to determine 
the rate and duration of LP release by stimulated cells. Dead S. albus were added to a 
series of tubes containing 100  X  106 PWBC, and supernatant fluid was removed from 
two tubes by centrifugation every 4  hr during a  24 hr period,  and new  supernatant 
containing only plasma and MHS was added. Each sample of supernatant was tested 
for its content of pyrogen. Beginning by 4  br, leukocytic pyrogen was produced at a 
constant rate  for  about  12-16  hr  after  which production  declined  (Fig.  1)  so  that 
after 16 hr, no further LP release occurred. To study the effects of repeated centrifuga- 
fion and manipulation on LP production by cells,  other suspensions were allowed to 
incubate 8,  12,  or  16 hr before subsequently replacing the supernatant every 4  or  8 
hr (Fig. 1). Under these conditions, pyrogen release was detectable for up to 12-16 hr. 
s Specific activity 5.4-6.3 mCi/mM. New England Nuclear Corp., Boston, Mass. 
9 Flow Laboratories, Inc., Rockville, Md. 
10 Dow Chemical Co., Midland, Mich. 
n Kontes Glass Co., Vineland, N. J. 
12 New England Nuclear Corp. 
18 Packard Model No. 3375. 730  ORIGIN  OF HUMAN  LEUKOC•TIC  PYROGEN 
Inhibition  o.f Protei~ Synthesis.--Puromycin  (19,  20)  and  cycloheximide (20,  21) 
are  capable  of  inhibiting  protein  synthesis  by  interfering  with  translation  of  mes- 
senger RNA (m-RNA). In the first series of experiments, either of these agents were 
added  to  the  cell suspensions  at the beginning of  the incubation  period with  the S. 
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FIc.  1.  Mean febrile responses of rabbits after the injection of LP derived from 15  X  106 
PWBC incubated with S. albus for the periods of time indicated. The number of rabbits in- 
jected is noted by the number in parentheses and the standard error of the mean indicated by 
the brackets. Experiments were done in duplicate as indicated by the pairs of bars. In the upper 
graph,  the media was changed every 4 hr from the beginning, while in the middle two,  the 
media was first changed at 8 hr and in the bottom at 16 hr. 
150,1- 
i 
I.OO~  (42) 
N 
o 
CONTROL 
(51) 
(53) 
CYCLOHEXIMrDE  PUROMYCIN 
FIG. 2.  Effect of cycloheximide and  puromycin on LP production  by human  PWBC  in 
vitro. Control cells (100 X  106 ]?WBC)  were incubated for 16 hr at 37°C with S. a/bus only. 
To the other suspensions,  either cycloheximide (2.5 #g/ml) or puromycin (4 X  10  -6 M) and S. 
albus were added together and incubated for 16 hr. Mean febrile response is indicated by the 
bar graph and the standard error of the mean by the brackets. The number of rabbits injected 
is denoted by the number in parentheses. 
albus and  the entire contents incubated  for  16 hr.  The supernatant  fluids were then 
tested  for  pyrogenicity.  Cycloheximide  completely  suppressed  all  LP  production 
(Fig. 2). Puromycin also showed significant suppression of LP production (P  <  0.005, 
t test), but it was not as complete as cycloheximide (Fig. 2). NORDLU-ND~  ROOT,  AND  WOLFF  731 
To exclude inhibition of pyrogenicity of LP by the drugs, cycloheximide, puromycin, 
actinomycin D,  sodium  fluoride, and  potassium  cyanide were  added to  preformed 
leukocytic pyrogen in the same concentrations as in the cell suspensions and incubated 
for  1 to 7 days prior to injection into rabbits. Under these conditions, there was no 
diminution of pyrogenicity (Table I) by any of these agents. 
Since it is possible that the drugs employed reduced LP production by killing the 
cells, a second series of experiments was performed. PWBC's were incubated at 37°C 
with plasma, MHS, and cycloheximide or puromycin in an appropriate concentration 
for 4 hr, but without the addition of S. albus. After centrifugation, the supernatants 
were discarded, the cells washed twice in  10-15  ml of MHS,  and divided into two 
equal parts. One part was resuspended in plasma (1.5 ml) and MHS (8.5 ml) and S. 
albus was added. To  the other part,  1 ml of drug was added as well as plasma (1.5 
TABLE I 
Pyrogenicity of Preformed LP Incubated with Drugs* 
Control  Cycloheximide  Puromycin  Acfinomycin D  Sodium fluoride 
Experi- 
ment  No.:~  Mean  SE  No.  Mean  SE  No.  Mean  sE  No.  Mean  sE  No.  Mean sE 
AT°C§  AT°C  AT°C  AT°C  AT°C 
I  2  1.35  0.10  4  1.15  0.06  3  0.88[t  0.04 
II  4  0.95  0.06  5  1.27][  0.02  3  1.23  0.22 
III  5  1.35  0.09  2  1.05  0.10  2  0.95  0.15 
IV  2  1.28  0.12  2  1.15  0.05  2  1.18  0.12 
V  7  1.11  0.06  4  1.31  0.15  3  1.22  0.19  3  1.22  0.12 
VI  3  1.05  0.06  2  0.92  0.12 
VII  3  1.25  0.10  6  1.14  0.07 
Total  26  1.17  0.04  17  1.21  0.04  13  1.09  0.08  8  1.08  0.02  3  1.22  0.12 
* LP derived from incubation of 15 >(  10  s PWBC for 18 hr with S. albus. 
:~ Number of rabbits injected. 
§ Maximum temperature (°C) change from baseline during the 1st hr after injection of LP. 
l] P  >  0.05 compared to control; t test. 
ml), MHS (7.5 ml), and S. albus. All mixtures were then incubated with agitation for 
16 hr at 37°C. Those cells exposed to drug for the second period of incubation did not 
produce LP, although cells washed free of drug after 4 hr could still produce amounts 
of LP comparable to controls (Fig. 3). 
To study if both cycloheximide and puromycin exerted their effects on LP produc- 
tion by the inhibition of phagocytosis, smears of cell suspensions containing drugs and. 
S. albus were stained with Wright's stain after 1 hr in a shaking incubator and the per 
cent of phagocytic cells containing S. albus counted. Table II shows that there was no 
inhibition of phagocytosis by cells exposed to the drugs employed. 
To test whether the cells were metabolically responsive during and after exposure 
to these drugs, the 14CO~ production from the hexose monophosphate shunt was meas- 
ured.  Puromycin and,  frequently, cycloheximide caused  a  slight but significant in- 
crease of 14CO2 production in resting cells to which no polystyrene balls had  been 
added (Table III). The addition of polystyrene balls to induce phagocytosis in other 
suspensions containing drugs showed equal increments in  CO2 release compared to 732  ORIGIN  OF  HUMAN  LEUKOCYTIC PYROGEN 
controls (Fig. 4). Moreover, even after 4 hr of preexposure to drugs, resting and stimu- 
lated  (phagocytic)  cells  were  capable  of  releasing  CO2  in  amounts  comparable  to 
controls (Fig. 5). Thus, cell viability and metabolic responsiveness did not seem to be 
impaired  by  prior  exposure  to  cycloheximide  or  puromycin  as  determined  by  the 
parameters  of  pyrogen  release,  phagocytosis,  and  hexose  monophosphate  shunt 
activity. 
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FIG.  3.  PWBC were incubated for 4 hr at 37°C with cycloheximide, puromycin, or no pro- 
tein inhibitor (control). After washing, S. albus was added to all suspensions,  and either cyclo- 
heximide or puromycin was added to one-half of the suspensions  previously exposed  to one of 
these drugs (0-4, 4-16 hr). The remaining suspensions  were not reexposed to cycloheximide or 
puromycin (0-4 hr).  All suspensions  were then incubated for 16 hr and supernatant  derived 
from 15 X  106 PWBC injected into rabbits. The mean temperature change and the standard 
error of the mean is recorded. The number in parentheses  denotes the number of rabbits in- 
jected. 
To ascertain whether  the effects of these drugs were peculiar to S. albus-acfivated 
cells,  similar  experiments  using  endotoxin-stimulated  ceils were performed.  The  re- 
sults  show  that  cycloheximide also  completely  suppressed  LP  production  by  cells 
exposed to endotoxin (Table IV). 
RNA Inhibitors.--In order to interrupt  the transcription  process of protein produc- 
tion,  actinomycin D  (22),  and vincristine (23,  24)  were used in experiments exactly 
as described above for the cycloheximide and puromycin. The addition of actinomycin 
D  completely suppressed  LP formation by cells incubated  with S. albus (Fig. 6). No 
such  effects  were  noted  when  vincristine was  used  (Fig.  6).  When  cells were  pre- 
incubated with actinomycin D  for 4 hr,  and washed twice prior to the addition of S. 
albus,  they were still unable  to produce LP  (Fig.  7). The addition of actinomycin D NORDLUND~  ROOT,  AND  WOLFF  733 
to cells and S. albus did not impede phagocytosis as is shown in Table II. Moreover, 
the ceils exposed to actinomycin D  for 0-4 hr before the addition of polystyrene balls 
demonstrated  hexose monophosphate  shunt  activity equivalent to  control  cells not 
exposed to actinomycin D  (Fig. 8), indicating that there was no loss of cell viability. 
Temporal  Relationships.--To  determine  the  duration  of  the  requirements  for 
m-RNA and protein synthesis for maximal pyrogen release, actinomycin D  or  cyclo- 
TABLE II 
Effect of Metabolic Inhlbitors on Phagocytosis* 
Experiment  Control  Cycloheximide  Puromycin  Actinomycin D 
%~  %  %  % 
I  86  78  86 
II  73  82  78  79 
III  96  96  98  99 
IV  92  93  87  88 
V  68  75  68  71 
Total  83  85  83  84 
* PWBC incubated with S. albus for 1 hr, were smeared on glass slides,  and  stained  with 
Wright's stain. 
J; Per cent of granulocytes and monocytes containing bacteria. 
TABLE III 
Effect of Drugs on Hexose Monophosphate Shunt Activity in Resting Cells 
Experi- 
ment 
Control  Cycloheximide  Puromycin 
No.  Mean  SE  No.  Mean  sE  P:~  No.  Mean  SE  P 
DPM§  DPM  DPM 
I  9  1766  71  8  2149  58  <0.001  9  1980  33  <0.02 
II  9  1685  85  9  1488  34  >0.05  9  2120  74  <0.01 
III  9  2218  68  9  2826  91  <0.001  9  2648  83  <0.001 
IV  8  1893  39  9  1960  47  >0.20  9  2089  59  <0.01 
* Number of individual vials prepared in each experiment. 
t test. 
§ 14CO2 release from cells incubated  with 14C-l-glucose  without  addition  of  polystyrene 
balls. 
heximide were added to cells at either 1, 2, or 4 hr after the addition of S. albus and  al- 
lowed to incubate for an additional time to cover a total incubation period of  16 hr. In 
the 4 hr experiments, the supernatant was replaced by fresh media, since previous ex- 
periments demonstrated LP generation within 4 hr (Fig. 1). When compared to control 
preparations  incubated  18 hr without drugs,  both  cycloheximide and  actinomycin D 
completely suppressed  LP generation when added  1 hr after the addition of S. albus 
(Table V). Addition of drugs  at 2  hr led to detectable but significantly reduced LP 734  ORIGIN OF HUMAN  LEUKOCYTIC  PYROGEN 
release, indicating that some m-RNA had been formed and protein translated  for LP 
production prior to this time. When added at 4 hr, larger quantities of LP were sub- 
sequently evolved, although less than in control solutions, suggesting that continuous 
m-RNA  and  protein  synthesis were necessary  for maximum  LP  generation  even to 
this late period. 
Energy Requirements.--In experiments  using  rabbit  leukocytes,  the  presence  of 
NaF in cell suspensions  incubated  with  heat-killed pneumococci suppressed  pyrogen 
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FIG.  4.  The mean 14CO2 release (dpm)  from 10 X  106 PWBC incubated with 14C-l-glucose 
for 1 hr at 37°C without stimulation (resting ceils) or with stimulation by phagoeytosis of poly- 
styrene balls (PSB). Either cycloheximide (2.5 #g/ml) or puromycin (4 X  10  -6 ~a) were added 
with polystyrene balls to some suspensions.  The standard  error of the mean is denoted by 
brackets and the number of suspensions  by the number in parentheses. 
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FI6.  5.  10 X  106 PWBC were incubated with either puromycin (4 X  10  -6 ~) or cyclohexi- 
mide (2.5 #g/ml) for 4 hr at 37°C before the addition of polystyrene balls (PSB) to stimulate 
14CO2 release from 14C-l-glucose by phagocytosis. Neither drugs nor PSB were added to resting 
cells,  and only polystyrene balls were added  to control stimulated cells.  Bars indicate mean 
14CO2 release,  and the brackets denote the standard error of the mean. Number of suspensions 
is indicated by the number in parentheses. 
release only when this agent was added prior to phagocytosis (25), suggesting that the 
failure of pyrogen production was due to impaired phagocytosis,  a  process which re- 
quires energy derived from glycolysis (17).  Similar experiments were performed with 
human leukocytes and in contrast to the above findings reported for rabbit cells, NaF 
added  1 hr after  the initiation of phagocytosis also suppressed  pyrogen output  (Fig. 
9). On the other hand,  if the cells and bacteria were allowed to incubate for 2 hr prior 
to the addition of NaF, this suppressive effect was lost. In preparations incubated for 
1 hr prior to the addition of NaF, the mean percentage of granulocytes and monocytes 
in three representative experiments which had ingested bacteria was 82%  (range  77- NORDLUND~  ROOT~  AND  WOLFF 
TABLE  IV 
Effect of Cycloheximlde on LP Generation by Endotoxin Activated PWBC 
735 
Experiment 
Controls  Cycloheximide 
Endotoxin  and PWBC*  Endotoxin  and  PWBC 
No.,+  Mean  SE  No.  Mean  SE  ~D§ 
~ToCII  zXT°C 
I  3  0.83  0.04  6  0  0  <0.001 
II  6  0.87  0.10  5  0  0  <0.001 
Total  9  0.86  0.06  11  0  0  <0.001 
* E. coli endotoxin (0.03 ~g/ml) incubated with 100  X  106 PWBC in 10 ml solution and 
1.5 ml supernatant injected into endotoxin tolerant animals. 
:~ Number of rabbits injected. 
§ t test. 
[I Maximum temperature (°C)  change from baseline during the 1st hr after injection  of 
supernatant. 
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FIG. 6.  PWBC to which S. albus alone or S. albus and either actinomycin D  (5.0 #g/ml) or 
vincristine (2  X  10  -5 ~) were incubated 16 hr at 37°C.  Supernatant derived from 15  )<  106 
PWBC was injected into rabbits and the mean maximum temperature change (°C) and stand- 
ard error (brackets) graphed. The numbers in parentheses indicate the number of rabbits in- 
jected. 
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Fie.  7.  PWBC  previously exposed to  actinomycin D  (5  /zg/ml)  for 4  hr at 37°C  were 
washed and reincubated with S. albus, only, for 16 hr. Control cells were similarly treated but 
were not exposed to actinomycin D at any time. The supernatant from the second incubation 
equivalent to 15 X  106 PWBC was injected into rabbits and mean febrile responses and stand- 
ard error recorded. The number in parentheses indicates the number of rabbits injected. 736  ORIGIN  O~'  HUMAN  LEUKOCYTIC  PYROGEN 
86%). That this amount of phagocytosis was sufficient to fully activate the cells for 
pyrogen release was  demonstrated  in  control preparations  in which  the  leukocytes 
were washed free of uningested bacteria after 1 hr of incubation and allowed to incu- 
bate in fresh medium for the subsequent 15 hr (Fig. 9). Under these conditions, pyro- 
gen production was equivalent to control suspensions in which cells were left in con- 
tact with bacteria for the entire 16 hr period (Fig. 9). These findings agree with earlier 
Cells without Preincubalion  Cells Preincubeted  4 Hr  with 
F  (4}  Aclinomycin  0 
RESTING RESTING PSB  PSB  RESTING  RESTING  PSB  PSB 
CELLS  CELLS  WITH  CELLS CELLS  WITH 
WITH  ACTINOMYCIN  D  WITH  ACTINOMYCIN  D 
ACTINOMYCIN D  ACTINOMYCIN  D 
FIo.  8.  The left set of bar graphs depicts  the effect of actinomycin  D  (5.0/zg/ml) on  the 
release of 14CO2 from 14C-l-glucose  by nonphagocytizing (resting) cells  and cells phagocytizing 
polystyrene  balls (PSB). Identical comparisons are made in the right set of bar graphs after 
preincubation of the leukocytes for 4 hr at 37°C with actinomycin  D  (5.0/~g/ml)  and  wash- 
ing before further exposure to acfinomycin D. The experiments were each performed  twice 
(shown by the double bars) and the results given as the mean and standard  error for triplicate 
or quadruplicate determinations  (numbers in parentheses). 
TABLE V 
The Effect on LP Generation  of Addition  of Actinomycin D  or Cycloheximide  I, 2, or 
Hr after S. albus 
Actinomycln D  Cycloheximide 
Ex-  Control 
peri-  1 hr  2 hr  4 hr  1 hr  2 hr  4 hr 
merit  Mean*  Mean  Mean  Mean  Mean  Mean  Mean 
AT  SE  AT  SE  AT  SE  z~T  SE  AT  s~  AT  sE  AT  SE 
I  0.93  0.09  0.125  0.08  0.44~  0. I0  0.70~  0.05  0.05~  0.05  0.28~  0.07  0.625  0.06 
II  1.18  0.05  0.315  0.14  0.735  0.09  0.78~  0.0S  0.25~  0.07  0.755  0.05  0.87~  0.09 
III  1.02  0.15  0.425  0.12  1.01  0.16  0.841  0.04  --  --  0.52:~  0.03  1.06  0.06 
* Temperature  (°C) change from baseline during the 1 hr after the injection of supernatant 
P  <  0.05 compared  to control (student  t test). 
data (14).  Finally, in two experiments, the increment in per  cent phagocytizing cells 
between 1 and 2 hr incubation was only 3-9%  (83-92%,  and  63-66%),  an amount 
not  sufficient to  explain the  difference in LP  production  by preparations  to  which 
sodium fluoride had been added at  1 and  2 hr,  respectively. These findings indicate 
that the suppression of LP production by NaF added at 1 hr is not due to inhibition 
of phagocytosis. Furthermore, the failure of NaF added at 2 hr to inhibit LP release 
suggests that blockade of glycolysis prevents the initial phase of cell activation, rather 
than release of the LP molecule itself. NORDLUND,  ROOT,  AND  WOLFF  737 
In other experiments,  the cytochrome oxidase inhibitor, potassium  cyanide,  was 
added to phagocytizing cells to study the role of aerobic glycolysis in supplying energy 
for LP generation.  LP output in these preparations was equivalent to controls incu- 
bated without potassium cyanide, indicating  that aerobic glycolysis had no significant 
role in energy production for LP generation. 
1.50 I  (36) 
0.50 
(f9) 
0 ~  ~  _ 
CONTROL SODIUM FLUORIDE SODIUM  S Qlbus 
ADDED AT  FLUORIDE WASHED  OUT 
I  HR  ADDED AT  .AT  I  HR 
AFTER  2 H  R 
S, albus  AFTER 
S. albus 
Fro.  9.  S. albus were added to all suspensions containing 100 X  106 PWBC. To some sus- 
pensions, sodium fluoride (2 X  10  -2 ~J) was added at 1 or 2 hr after the S. albus  and  the cells 
incubated for 16 hr. To remove nonphagocyfized bacteria, other preparations were washed 1 
hr after adding S. albus and reincubated for 16 hr in new media. Supernatant from 15 X  106 
PWBC was injected into rabbits, and the mean temperatures were recorded and the standard 
error calculated. The number of rabbits injected is indicated by the number in parentheses. 
DISCUSSION 
In contrast to cells derived from inflammatory exudates, rabbit and human 
blood leukocytes ~  not release pyrogen spontaneously unless activated by a 
specific stimulus  such  as phagocytosis (2,  12,  14,  25)  or exposure to various 
agents, including endotoxin (2,  14, 26,  27)  and etiocholanolone (28,  29). Two 
phases appear to be involved in the elaboration of pyrogen by stimulated cells. 
During  the first,  or "activation" phase,  cellular metabolism becomes altered 
in such a way that pyrogen release can subsequently take place in the absence 
of any further stimulus (14, 25, 29). The second phase, that of pyrogen release, 
occurs only after a latent period which varies with the type of agent used to 
activate  the  cells.  The present  data provide information on mechanisms  in- 
volved in both phases, using phagocytosis of heat-killed bacteria as the primary 
mode of stimulation. 
In a previous study, it was noted that after the ingestion of heat-killed S. 
albus, pyrogen release was not readily detectable until 3-4 hr incubation time, 
although  trace amounts  could be detected earlier,  using huge  test  doses for 
assay (14, 30). As shown in the present study, pyrogen release then occurs at a 
steady rate until  12-15 hr after the start of incubation. This differs from re- 
ported studies  on rabbit peritoneal exudate cells which demonstrated failure 738  ORIGIN OF  HUMAN LEUKOCYTIC PYROGEN 
of granulocytes and monocytes to produce pyrogen beyond 3  and  7  hr,  re- 
spectively (4). Such differences are probably due to species variability and the 
conditions  used  to  obtain  and  stimulate  the  cells.  Activation was  found to 
relate directly to the per cent of phagocytizing cells and to require  approxi- 
mately 60 rain after the addition of bacteria to become maximal (14). 
Several previous studies have been undertaken to delineate the role of RNA 
and protein synthesis in the formation of LP by stimulated cells. When rabbit 
exudate granulocytes were  employed, little  or  no  suppression  of LP  release 
was  found when puromycin or actinomycin D  were added to the incubation 
medium (30,  31). On the other hand, when the rabbits were pretreated with 
chloramphenicol for several  days  before the  exudates  were  harvested,  some 
depression of LP release was noted, leading to the conclusion that the molecule 
might be preformed in vivo and bound  in  an  inactive state within the  cells 
until release in vitro by incubation of the leukocytes in saline (31). In contrast 
to the findings with peritoneal cells, studies on blood leukocytes have suggested 
that protein synthesis might be inlportant in the activation process in vitro. 
For instance, puromycin has been found to inhibit LP generation by specifically 
sensitized  rabbit  cells  exposed  to  tuberculin  (32),  and  actinomycin D  and 
puromycin suppressed release by human  leukocytes incubated with  etiocho- 
lanolone (33). These agents have also been reported to block pyrogen produc- 
tion by human cells activated by phagocytosis, although no data were given 
(34). 
The results  of the  present  study  indicate  that  synthesis  of both  m-RNA 
and protein are involved in the production of LP by phagocytizing cells derived 
from the peripheral circulation. Actinomycin D, an inhibitor of m-RNA trans- 
cription,  and  the  inhibitors  of  translation,  puromycin  and  cycloheximide, 
blocked LP production without altering cell viability, interfering with phago- 
cytosis, or inactivating the LP molecule itself. That these processes seem to be 
common to all modes of stimulation of human peripheral leukocytes for pyrogen 
release is suggested by the  ability of cycloheximide to inhibit LP production 
by  cells  exposed  to  endotoxin,  noted  in  the  present  investigation,  and  the 
ability of puromycin and actinomycin D  to block release from cells incubated 
with  etiocholanolone (33).  Furthermore, similar findings have been observed 
for  rabbit  peripheral  leukocytes  stimulated  by  phagoeytosis  or  endotoxin, 
using cycloheximide and puromycin as the inhibiting agents (35). 
The failure of these drugs to block LP release in earlier studies on peritoneal 
cells suggests that they act at the level of activation rather than on the release 
phase itself, since these cells  appear to be activated in vivo prior to removal 
from the donor (25). Further support for this concept was obtained when the 
effects of adding the  inhibitory drugs  at various times after the initiation of 
phagocytosis were  studied.  Complete suppression  of pyrogen production oc- 
curred when cycloheximide or actinomycin D  were added simultaneously with, NORDLUND,  ROOT, AND  WOLFF  739 
or 1 hr after, the start of incubation with S. atbus.  Progressively less inhibition 
was seen in preparations to which these agents had been added at 2 and 4 hr 
incubation,  respectively, times  at  which the cells  were  already significantly 
activated for LP  release.  This  indicates  that  ongoing m-RNA  and  protein 
synthesis are required for maximal LP production throughout the time period 
studied, but similar to the time required for maximal activation, the major 
requirements  are  early in the  course of incubation. Two conclusions can be 
arrived at from these findings: (a) m-RNA and new protein synthesis are more 
essential to cell activation than to pyrogen release per se; (b)  that the activa- 
tion phase might not consist simply of the formation of a  store  of pyrogen 
which is then released over the subsequent 12-16 hr. As will be discussed below, 
the effects of inhibition of glycolysis on pyrogen formation might have bearing 
on this point. 
Several  points  regarding  the  results  found with  the  individual inhibitors 
of m-RNA and protein synthesis should be noted. Actinomycin D  is known to 
inhibit m-RNA production by the formation of a strong bond with guanine on 
DNA  molecules  (22),  thereby blocking RNA  polymerase-mediated m-RNA 
production and prohibiting further protein synthesis. The tight bond between 
actinomycin D  and DNA  is  reversible  only under rather vigorous chemical 
conditions (22),  which would explain the observation that LP generation was 
irreversibly blocked by this drug. In contrast, the inhibition of pyrogen release 
by  cycloheximide and  puromycin was  reversible,  consistent  with  the  weak 
chemical bonding of these agents (20, 21). 
The failure of vincristine to duplicate the inhibitory effect of actinomycin D 
on pyrogen formation is interesting. In investigations utilizing Ehrlich ascites 
carcinoma cells, it has been observed that vincristine was most suppressive of 
soluble RNA (s-RNA) production and less so against m-RNA or nuclear RNA 
(23).  Minimal depression of protein synthesis was noted at 7 hr (20%), which 
became more marked by 16 hr incubation (50%)  (23).  In contrast, when neo- 
plastic human leukocytes were studied, vincristine was found to depress synthe- 
sis in all classes of RNA as determined by density gradient ultracentrifugation 
(24).  The incorporation of labeled amino acids into protein by the leukocytes 
was  also  suppressed  by vincristine,  although the  mechanism of  action was 
undear (24).  On the other hand, when mature normal granulocytes were em- 
ployed, there was no significant inhibition of tritiated uridine incorporation 
into RNA nor labeled amino acids into protein. The failure of vincristine to 
suppress LP production in the present investigation is consistent with these 
observations. 
Also of interest was the normal hexose monophosphate shunt  (HMS)  ac- 
tivity exhibited by resting  and phagocytizing leukocytes incubated for  1 hr 
with actinomycin D.  This finding is  in contrast  to  the  report  that  incuba- 
tion of normal human leukocytes with actinomycin D  resulted in depression 740  ORIGIN  OF  HUMAN  LEUKOCYTIC PYROGEN 
of 14CO2 release from the HMS  (36,  37). No obvious explanation for this dis- 
crepancy is  evident; it  does not seem reasonable that  the longer  incubation 
times employed in the present study could cause the difference. In contrast to 
actinomycin D,  both  cycloheximide and  puromycin caused  a  significant  in- 
crease in HMS activity of resting cells. 
Finally,  the  data  concerning the  energy requirements  for pyrogen release 
is  intriguing.  Earlier  investigations  on  rabbit  peritoneal  leukocytes  demon- 
strated that pyrogen release could be inhibited by sodium fluoride only when 
this agent was added to the incubation medium prior to phagocytosis, but not 
after phagocytosis had  occurred (25).  It was  concluded that  because  of the 
interference  with  glycolysis,  no  significant  phagocytosis,  and  therefore,  no 
activation of the leukocytes for pyrogen release had taken place. In contrast to 
these findings  with  rabbit  peritoneal leukocytes, in  the  present  studies  em- 
ploying human cells, the addition of sodium fluoride 1 hr after the initiation of 
phagocytosis completely suppressed pyrogen production. This inhibitory effect 
was lost if the cells were allowed to incubate with bacteria for 2 hr before add- 
ing sodium fluoride. The action of sodium fluoride did not appear to be medi- 
ated  through  interference with  phagocytosis,  since  there  was  no  significant 
difference in  the per cent phagocytizing cells at  1 and 2 hr.  Furthermore, in 
other preparations  not containing sodium fluoride, halting phagocytosis at  1 
hr by removing the cells from the bacteria did not lead to a suppression of LP 
output.  Potassium  cyanide-induced blockade of  aerobic metabolism  did  not 
affect pyrogen production. These findings suggest that for human leukocytes, 
the energy derived from glycolysis is important not only for phagocytosis  it- 
self,  but  also  for the  initial  intracellular  metabolic  activation  that  leads  to 
subsequent  pyrogen  formation.  Once  the  initial  activation  has  occurred, 
leukocytes  apparently  contain  enough  stored  utilizable  energy  for  pyrogen 
release, most likely as high energy phosphate bonds,  to bypass  the  blockade 
introduced by sodium fluoride and potassium cyanide. A similar situation has 
been noted during mitochondrial protein synthesis by liver cells in vitro (38, 39). 
The finding  that  activation  appears  to  be  maximal  during  the  1st  hr  of 
incubation  of cells with bacteria,  whereas  the  requirements for m-RNA  and 
protein synthesis for optimal LP release extend beyond this time, suggests that 
induction  of a  genome for LP  generation may take place during  this initial 
period.  If  this  is  true,  inhibition  of pyrogen production by sodium fluoride 
added prior to 2 hr raises the possibility that in mature human neutrophils and 
monocytes, the energy provided by anaerobic glycolysis might be essential for 
induction  of this genome, after which  the  cells are  then capable of utilizing 
stored energy both for m-RNA  transcription  and translation to new protein. 
An  alternative explanation is  derived from studies  on rabbit  reticulocytes in 
which addition of sodium fluoride caused a reversible degradation of polysomes 
into single ribosomes, thereby halting protein synthesis (40). Human leukocytes 
may be similar in that glycolytic energy is required for the integrity of poly- NORDLUND, ROOT, AND WOLFF  741 
somes during protein synthesis. Whether a portion of the new protein synthe- 
sized during the activation phase after phagocytosis is the LP molecule itself 
or an enzyme involved in freeing it from an  inactive precursor state  awaits 
further investigation. 
SUMMARY 
Release of the protein molecule, leukocytic pyrogen, is one of the many reac- 
tions exhibited by leukocytes after phagocytosis. After the ingestion of heat- 
killed S.  albus,  a  3-4 hr latent period exists,  during which human peripheral 
leukocytes release no pyrogen, yet cellular metabolism is altered in such a way 
that pyrogen output may subsequently occur in the absence of further phagocy- 
tosis.  Transcription  of messenger  RNA  and  translation  of  new  protein  are 
initial events in the activation process, since addition of the inhibitors, actino- 
mycin D,  and cycloheximide or puromycin, during  this period markedly de- 
pressed or abolished subsequent pyrogen release. These effects were noted to be 
dependent upon the time of addition of the inhibitors. None of the inhibitor 
drugs  interfered with cell viability as measured by phagocytosis and hexose 
monophosphate  shunt  activity,  nor  did  they  alter  the  pyrogenicity of  pre- 
formed  leukocytic  pyrogen.  Vincristine  did  not  inhibit  pyrogen  formation, 
consistent with its reported failure to alter RNA synthesis in mature human 
granulocytes. The glycolytic inhibitor,  sodium fluoride,  blocked pyrogen re- 
lease both when added prior to particle ingestion or 1 hr after the initiation of 
phagocytosis.  Whereas  inhibition  of phagocytosis would  explain  the  sodium 
fluoride effect prior to  1 hr,  this was  not observed in leukocyte preparations 
incubated for 1 hr with S.  albus before adding sodium fluoride. When sodium 
fluoride was  added to preparations 2 hr after the start of incubation, the LP 
production was unimpaired. Potassium cyanide had no effect on cell activation 
or pyrogen release. These findings suggest that the primary energy supply for 
the activation process is derived from high energy phosphate bonds provided 
by anaerobic glycolysis. Since the major amount of cell activation appears to 
occur in the  1st hr after phagocytosis, this energy might be involved in the 
induction of a genome leading to the transcription of m-RNA and its transla- 
tion  into  new  protein  or  is  required  for  polysome  integrity  during  protein 
synthesis. It is suggested that this new protein may be leukocytic pyrogen it- 
self, or an enzyme responsible for cleaving it from an inactive precursor. 
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